Unicyte Ev AG
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
May 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 16, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,716,813 | Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia In force · From the USPTO record | In force | From the USPTO record | |
| US 11,110,130 | Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia In force · From the USPTO record | In force | From the USPTO record | |
| US 12,208,120 | Composition of Extracellular Vesicles (EVS) and Medical Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,395,832 | Pharmaceutical carriers containing miRNAs for use in the treatment of renal cancer In force · From the USPTO record | In force | From the USPTO record | |
| US 11,464,799 | A Composition of Extracellular Vesicles (EVS) and Medical Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,484,816 | Isolation of extracellular vesicles (EVs) from biological fluid samples In force · From the USPTO record | In force | From the USPTO record | |
| US 12,285,726 | Use of a Filter Module for Filtering a Biotechnical Liquid and Filter Module for the Filtration of a Biotechnical Liquid In force · High confidence | In force | High confidence | |
| US 12,239,671 | Extracellular vesicles derived from human liver stem cells (HLSCs) In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 no status recorded